report News - The Latest News, Insight, Commentary & Analysis at Healthcare Asia Magazine

report

Urology devices market to hit $46.26b by 2030

Urology devices market to hit $46.26b by 2030

Thanks to a rise in conditions that require diagnostic and treatment interventions.

Diagnostics firms to boost R&D spending on home testing by 2035

More than half have already commercialised home or self-testing products.

Medical gas application and equipment market to hit $393.01b by 2034

Thanks to a rise in hospitals, ambulatory centres, and speciality clinics.

Global capnography equipment market to hit $670k by 2030

Its growth is driven by the rising prevalence of respiratory ailments.

Molecular spectroscopy market to be valued at $6.4b by 2034

Key sectors include pharmaceuticals and biotechnology.

8 in 10 Singaporeans delay medical care for work, family

More than half said they lacked the right information to make treatment decisions.

Indonesia’s MedTech import market hit $3.28b in 2024

The market rebounded by 77.8% after contracting to $1.79b in 2022.

Global disposable medical device market to hit $144.85b by 2030

Its expansion is attributed to growing concerns over hospital-acquired infections.

mRNA vaccine venture financing plunges 82% to $90m in 2025 YTD

The decline follows a $500m cut in grant support by the US HHS.

Blood collection devices market to be valued at $13.02b by 2030

One key driver is the emergence of liquid biopsy tests.

Global neurovascular devices market to hit 7.22b by 2030

However, high costs and strict regulations may challenge growth.

APAC eyes fastest growth in global companion diagnostics market

Thanks to the rapid development of localised solutions in China, Japan, and India.

Japan’s ultrasound systems market to reach $1.27b by 2034

The country represented 30% of the Asia-Pacific market in 2024.

APAC nuclear imaging agents market to hit $1.1b by 2034

China made up over half of the region’s market in 2024.

Two in three older Singaporeans underestimate shingles risk: report

Only 25% plan to discuss prevention with their doctor within the next three months.

What lies ahead for the Glomerulonephritis market?

Ongoing clinical trial activities drive market growth.

Japan’s hip reconstruction market to be valued at $570m by 2036.

The country accounted for around 30% of the APAC market in 2024.